title: Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
abstract: Carbapenem resistance presents severe threat to the treatment of multidrug resistant Pseudomonas aeruginosa infections. The study was undertaken to investigate the role of efflux pumps in conferring meropenem resistance and effect of single dose exposure of meropenem on transcription level of mexA gene in clinical isolates of P. aeruginosa from a tertiary referral hospital of India. Further, in this investigation an effort was made to assess whether different components of MexAB-OprM operon expresses in the same manner and the extent of contributions of those components in meropenem resistance in its natural host (P. aeruginosa) and in a heterologous host (E. coli). Out of 83 meropenem nonsusceptible isolates, 22 isolates were found to possess efflux pump activity phenotypically. Modified hodge test and multiplex PCR confirmed the absence of carbapenemase genes in those isolates. All of them were of multidrug resistant phenotype and were resistant to all the carbepenem drug tested. MexAB-OprM efflux pump was found to be overexpressed in all the study isolates. It could be observed that single dose exposure meropenem could give rise to trivial increase in transcription of mexA gene. Different constructs of MexAB-OprM (mexR-mexA-mexB-OprM; mexA-mexB-OprM; mexA-mexB) could be expressed in both its natural (P. aeruginosa PAO1) and heterologous host (E. coli JM107) but transcription level of mexA gene varied in both the hosts before and after single dose exposure of meropenem. Different components of the operon failed to enhance meropenem resistance in E. coli JM107 and P. aeruginosa PAO1. This study could prove that MexAB-OprM efflux pump can significantly contribute to meropenem resistance in hospital isolates of P. aeruginosa where an acquired resistant mechanism is absent. Thus, equal importance should be given for diagnosis of intrinsic resistance mechanism so as to minimize treatment failure. As meropenem could not enhance mexA transcriptions significantly, there might be a possibility that the increase in expression of efflux pump genes does not mediated by single antibiotic but rather by a combination of antipseudomonal drugs which are used during treatments. Early detection of efflux genes will help in selection of proper therapeutic options.
authors.affiliation: Department of Life Science & Bioinformatics, Assam University, Silchar, Assam, India.
authors.forename: Debarati
authors.initials: D
authors.lastname: Choudhury
authors.affiliation: Department of Life Science & Bioinformatics, Assam University, Silchar, Assam, India.
authors.forename: Anupam
authors.initials: A
authors.lastname: Das Talukdar
authors.affiliation: Department of Life Science & Bioinformatics, Assam University, Silchar, Assam, India.
authors.forename: Manabendra
authors.initials: M
authors.lastname: Dutta Choudhury
authors.affiliation: Department of Microbiology, Assam University, Silchar, Assam, India.
authors.forename: Anand Prakash
authors.initials: AP
authors.lastname: Maurya
authors.affiliation: Department of Microbiology, Assam University, Silchar, Assam, India.
authors.forename: Deepjyoti
authors.initials: D
authors.lastname: Paul
authors.affiliation: Department of Microbiology, Silchar Medical College and Hospital, Silchar, Assam, India.
authors.forename: Debadatta
authors.initials: D
authors.lastname: Dhar Chanda
authors.affiliation: Department of Microbiology, Silchar Medical College and Hospital, Silchar, Assam, India.
authors.forename: Atanu
authors.initials: A
authors.lastname: Chakravorty
authors.affiliation: Department of Microbiology, Assam University, Silchar, Assam, India.
authors.forename: Amitabha
authors.initials: A
authors.lastname: Bhattacharjee
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics*; D001426:Bacterial Proteins / Q000235:genetics; D003001:Cloning, Molecular; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D007194:India; D026901:Membrane Transport Proteins / Q000235:genetics; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D009876:Operon / Q000235:genetics; D010641:Phenotype; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology / Q000235:genetics* / Q000302:isolation & purification; D062606:Tertiary Care Centers; D013845:Thienamycins / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects*; D001618:beta-Lactamases / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D026901:Membrane Transport Proteins; C118598:MexA protein, Pseudomonas aeruginosa; C118597:MexB protein, Pseudomonas aeruginosa; C402263:OprM protein, Pseudomonas aeruginosa; D013845:Thienamycins; D001618:beta-Lactamases; C063912:carbapenemase; D000077731:Meropenem